ALX Oncology Holdings Inc. (ALXO) has filed its definitive proxy statement (DEF 14A) for its 2026 annual stockholders' meeting, to be held virtually on June 10, 2026. Stockholders will vote on the election of three Class III directors, an advisory "say-on-pay" resolution for named executive officer compensation, and the ratification of KPMG LLP as the independent registered public accounting firm. The filing also details executive compensation, including base salaries, cash incentives, and equity awards, along with information on director independence, board structure, and related-party transactions.

LIR Life Sciences Corp. has entered into a Technology Development Collaboration Agreement with Resilience BioSciences Inc. to support and expand LIR's preclinical research activities. This collaboration will involve LIR conducting early-stage experimental work at RBI's state-of-the-art facilities located at the University of British Columbia, leveraging the academic environment and experienced scientific teams for efficient and cost-effective study progression. LIR will pay RBI $5,000 per month for an initial six-month term, with potential for future application of LIR's delivery technology in RBI's own development programs.

Zspace Inc. is expanding the integration of augmented and virtual reality (AR and VR) in STEM and career education by inviting educators and students to observe real-world classroom applications and success stories. The company promotes its YouTube channel for insights into how immersive technology transforms learning. These efforts, including past collaborations and initiatives, highlight Zspace Inc.'s commitment to using technology to improve educational environments.

The Rosen Law Firm has announced an investigation into potential securities claims against ADMA Biologics, Inc. following allegations of misleading business information. This comes after a short seller report claimed ADMA Biologics engaged in "channel stuffing" which caused the company's stock to drop. Investors who purchased ADMA Biologics securities are encouraged to contact the law firm to join a potential class action lawsuit.

The semiconductor equipment sector is experiencing significant momentum, driven by the increasing global demand for advanced chips. Axcelis Technologies, a provider of ion implantation systems for chip manufacturing, is highlighted as a key player benefiting from this trend through its focus on innovation. The article suggests that strong performance in this sector indicates expansion and technological advancements shaping future digital infrastructure.

Vulcan Materials, a leading U.S. construction aggregates producer, is well-positioned to benefit from ongoing infrastructure spending and long-term economic growth. Its core business model, focused on quarrying and distributing essential materials like crushed stone and sand, provides predictable cash flows and resilience against economic downturns. Investors seeking exposure to domestic construction and stable returns may find Vulcan Materials a compelling opportunity.

Michael Dean Brown, an insider at Travel + Leisure Co. (NYSE:TNL), sold 9,443 shares of the company's stock on April 17th for approximately $747,036, reducing his holding to 487,303 shares. This sale was part of several recent insider transactions, including significant disposals in February. The company recently increased its quarterly dividend to $0.60 per share, offering a 3.1% yield, and analysts maintain a "Moderate Buy" consensus rating with an average price target of $85.90.

Trinity Industries Inc (TRN) stock fell 3.2% to $31.90, despite a strong year-to-date performance. The stock is considered 42.4% overvalued based on its GF Value™ of $22.40, and holds a GF Score™ of 68/100, indicating above-average overall performance but weak financial strength and growth. While its P/E ratio is below its historical median, the significant overvaluation and lack of insider transactions suggest caution for investors.

Trinet Group Inc (TNET) shares increased by 3.5% to $40.12, but GuruFocus' GF Value™ indicates the stock is still significantly undervalued at 62.5% below its estimated fair value of $106.94. Despite its undervaluation and an "above average" GF Score™ of 68/100, the stock is labeled a "Possible Value Trap" due to weak valuation and momentum ratings, and a lack of recent insider buying. Investors are cautioned to consider both the potential undervaluation and the associated risks.

Tecnoglass Inc (TGLS) stock increased by 3.8% to $45.81, with GuruFocus (GF) Value indicating it is significantly undervalued by 30.9% compared to its intrinsic value of $66.30. The company has a strong GF Score of 88/100, driven by excellent profitability and growth, and has seen notable insider buying, signaling strong confidence in its future. Investors are advised to perform thorough research despite the attractive valuation and positive insider activity.